Ebola Vaccine Trial (Ad26.ZEBOV/MVA-BN-Filo)

Condition:   Ebola Virus Disease Intervention:   Drug: Ad26.ZEBOV/MVA-BN-Filo Sponsors:   MRC/UVRI Uganda Research Unit on Aids;   Epicentre, Paris, France and Mbarara, Uganda;   Janssen Pharmaceutica N.V., Belgium;   Coalition for Epidemic Preparedness Innovations Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials